openPR Logo
Press release

Prefilled Syringes Market Supply, Demand, Trendss, Growth Analysis by Top Key Player- Becton, Dickinson and Company, Eli Lilly and Company, Amgen Inc., Baxter International Inc., Bayer AG, Pfizer Inc., F. Hoffman-La Roche AG, and Novartis AG

11-26-2018 05:51 AM CET | Health & Medicine

Press release from: P&S Intelligence

Prefilled Syringes Market Supply, Demand, Trendss, Growth

Prefilled syringes market is expected to attain a size of $7.5 billion by 2023, according to P&S Intelligence.Increasing demand for injectable pharmaceutical products, advanced applications of combination therapies for the management of diseases, rising prevalence of chronic and lifestyle associated diseases, benefits of prefilled syringes over traditional vial and syringe packaging systems, and technological advancements in syringes are the major factors driving the growth of the prefilled syringes market globally.

Explore Report Description with Detailed TOC on Global Prefilled Syringes Market at: https://www.psmarketresearch.com/market-analysis/prefilled-syringes-market

Prefilled syringe drug delivery systems are frequently used in the treatment of diabetes, rheumatoid arthritis, anaphylaxis, and other diseases, such as multiple sclerosis, anemia, and psoriasis. The application of prefilled syringes for diabetes is expected to lead the global market, advancing at a CAGR of 9.0% during the forecast period. Increasing prevalence of diabetes across the world is the key factor contributing in the growth of the prefilled syringes market. This is substantiated by the fact that, according to the World Health Organization (WHO), the prevalence of diabetes among adults over 18 years of age has risen from 4.7% in 1980 to 8.5% in 2014, globally.

Request to sample: https://www.psmarketresearch.com/market-analysis/prefilled-syringes-market/report-sample

During the forecast period, the prefilled syringes market is forecasted to witness the fastest growth in APAC, at a CAGR of 9.6%. This growth is attributed to the rising geriatric population, and surge in the prevalence of different chronic diseases in the region. According to the UN publication, World Population Aging Report 2017, the population aged 60 years and above is expected to increase from 10.0% in 2010 to approximately 25.0% by 2050. This increase in the aging population is expected to create high demand for prefilled syringes, to eliminate the occurrence of various chronic diseases among the aged population.

Send Enquiry: https://www.psmarketresearch.com/send-enquiry?enquiry-url=prefilled-syringes-market

The companies operating in the prefilled syringes industry are getting government approvals for various drugs used in syringes to increase their market share. For instance, in August 2018, Bristol-Myers Squibb Company received United States Food and Drug Administration (USFDA) approval for Opdivo (nivolumab), as the first and only Immuno-Oncology treatment option for patients with metastatic small cell lung cancer (SCLC), whose cancer has progressed after platinum-based chemotherapy.

Some of the other key players operating in the prefilled syringes industry are Becton, Dickinson and Company, Eli Lilly and Company, Amgen Inc., Baxter International Inc., Bayer AG, Pfizer Inc., F. Hoffman-La Roche AG, and Novartis AG.

About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Prefilled Syringes Market Supply, Demand, Trendss, Growth Analysis by Top Key Player- Becton, Dickinson and Company, Eli Lilly and Company, Amgen Inc., Baxter International Inc., Bayer AG, Pfizer Inc., F. Hoffman-La Roche AG, and Novartis AG here

News-ID: 1396790 • Views:

More Releases from P&S Intelligence

U.S. ESG Investments Market Set to Skyrocket: $16 Trillion by 2032
U.S. ESG Investments Market Set to Skyrocket: $16 Trillion by 2032
According to the latest market research study published by P&S Intelligence, the U.S. Environmental, Social, and Governance (ESG) investments market is experiencing a significant surge, with projections indicating an increase from $6.5 trillion in 2024 to an estimated $16.0 trillion by 2032. This represents a robust compound annual growth rate (CAGR) of 12.1% over the forecast period. According to a comprehensive analysis by P&S Intelligence, the market's expansion is driven
Facility Management in the U.K. Booms with 14.1% CAGR as Demand Soars Across Sectors
Facility Management in the U.K. Booms with 14.1% CAGR as Demand Soars Across Sec …
According to the latest market research study published by P&S Intelligence, the U.K. facility management market is poised for significant growth, with projected revenues reaching USD 2,743.3 million in 2024 and expected to soar to USD 6,038.4 million by 2030, reflecting a robust CAGR of 14.1% during the forecast period. This expansion is fueled by a surge in demand across both public and private sectors. According to the RICS U.K.
Point-of-Sale Software Market in the U.S. Set to Grow by 9.7% CAGR, Boosted by Omnichannel Integration
Point-of-Sale Software Market in the U.S. Set to Grow by 9.7% CAGR, Boosted by O …
According to the latest market research study published by P&S Intelligence, the U.S. point-of-sale (POS) software market, valued at USD 4.7 billion in 2024, is poised for significant growth over the coming years, with projections estimating it will reach USD 9.8 billion by 2032, expanding at a compound annual growth rate (CAGR) of 9.7%. This growth is attributed to rapid technological advancements, a surge in mobile and cloud-based POS systems,
Competitive Landscape of the Industrial Starches Market: Key Players, Trends, and Growth Opportunities
Competitive Landscape of the Industrial Starches Market: Key Players, Trends, an …
According to the latest market research study published by P&S Intelligence, the global industrial starches market is poised for significant growth, with a projected increase from USD 110.3 billion in 2024 to USD 169.9 billion by 2030, at a robust compound annual growth rate (CAGR) of 7.5%. Industrial starches play a crucial role in diverse sectors, including food, pharmaceuticals, and paper, driven by their unique properties such as stabilizing, thickening,

All 4 Releases


More Releases for Prefilled

Global Prefilled Syringes Market by Material (Glass Prefilled Syringes, and Plas …
The global prefilled syringes market size is anticipated to reach USD 10.5 billion by 2028, at a CAGR of 8.5% during the forecast period due to the high prevalence of chronic diseases and the rising adoption of self-injection devices. Global prefilled syringes market estimated to grow with a CAGR of 8.5% during the forecast period, 2021-2028. It is owing to the benefits of prefilled syringes such as the low risk of
Benefits of Prefilled Syringes over Traditional Vials and Syringes Driving Prefi …
In 2017, the global prefilled syringes market reached $4.7 billion and is projected to register an 8.3% CAGR during the forecast period (2018-2023). The market is growing because of the extensive pipeline of injectable drugs, rising demand for injectable pharmaceutical products, expanding pharmaceutical industry, increasing prevalence of chronic and lifestyle associated diseases, surging requirement for point-of-care administration, benefits of prefilled syringes over conventional vial and syringe packaging systems, regulations associated
07-23-2019 | Health & Medicine
Factmr
Prefilled Syringes Market - Increasing Use of Glass Prefilled Syringes to Aid th …
With increasing demand for efficient drug delivery systems, especially for injectable drug delivery, the need for innovative injectable drug delivery options has risen. Given the advantages of standalone drug injecting systems such as prefilled syringes, such as ease in use and enhanced safety, their demand is expected to increase at a high pace in the coming years. For more incisive insights, Request a Sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=603 According to Fact.MR analysis on prefilled syringes,
Development Of Technologically Advanced Prefilled Syringes Is Expected To Boost …
Small molecule prefilled syringes are pharmaceutical preparations of small molecule drugs that are sold in prefilled syringes. Small molecule prefilled syringes are alternatives to other dosage forms such as tablets and capsules. Empty glass or plastic and polymer syringes are filled with the solution of the active pharmaceutical ingredients. Drugs belonging to categories such as cardiovascular, analgesics, neurology, and adjuvants are offered in prefilled syringe delivery systems. Small molecule prefilled
Prefilled Safety Devices Market – Latest Advancements
Prefilled Safety Devices Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Prefilled Safety Devices market research report is a professional and in-depth study on the current state of Prefilled Safety Devices Industry. The Prefilled Safety Devices Market research report covers the present scenario and
Prefilled Syringes Market
Parenteral drugs are the second most preferred type of drugs after oral solid dosage forms and also holds second largest market share in terms of revenue in overall pharmaceutical market. Various benefits such as ease in administration, better patient compliance and 100% bioavailability are the few important factors that are expected to favor growth of the prefilled syringes market over the forecast period (2016–2024). Prefilled syringes segment is the one